Appetite stimulants use in cystic fibrosis

Show simple item record

dc.contributor.author Nasr, Samya Z. en_US
dc.contributor.author Drury, Donna en_US
dc.date.accessioned 2008-02-04T19:22:30Z
dc.date.available 2009-03-04T14:20:46Z en_US
dc.date.issued 2008-03 en_US
dc.identifier.citation Nasr, Samya Z.; Drury, Donna (2008). "Appetite stimulants use in cystic fibrosis." Pediatric Pulmonology 43(3): 209-219. <http://hdl.handle.net/2027.42/57930> en_US
dc.identifier.issn 8755-6863 en_US
dc.identifier.issn 1099-0496 en_US
dc.identifier.uri http://hdl.handle.net/2027.42/57930
dc.identifier.uri http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18219690&dopt=citation
dc.description.abstract Cystic fibrosis (CF) is an autosomal recessive disease. It affects multiple body organs. The lungs and pancreas are the most affected which results in progressive lung damage and pancreatic insufficiency. Due to the disease process, CF patients require significantly higher caloric intake than recommended for other individuals. The nutritional goal for CF patients is to achieve normal growth and development and, once genetic potential is reached, to maintain good nutritional status throughout life. Evidence has shown that lung function is closely associated with nutritional status in CF and that nutritional status is an independent predictor of survival. Most CF patients are on a high calorie diet to help achieve normal growth and development and maintain good lung function. Inadequate caloric intake in CF can lead to malnutrition. Malnutrition in CF requires careful, multidisciplinary history taking, physical exam, and overall patient/family assessment. Only by determining the actual cause of the malnutrition can appropriate and safe therapies be used to treat it. Appetite stimulants, although efficacious in treating malnutrition in CF, should only be prescribed if decreased food intake secondary to inadequate appetite is the principal cause of the malnutrition and all other contributing factors have been assessed, ruled-out or treated. In this review, we attempted to summarize the use of several appetite stimulants used in CF and other diseases to improve appetite and maximize caloric intake. Pediatr Pulmonol. 2008; 43:209–219. © 2008 Wiley-Liss, Inc. en_US
dc.format.extent 136727 bytes
dc.format.extent 3118 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.publisher Wiley Subscription Services, Inc., A Wiley Company en_US
dc.subject.other Life and Medical Sciences en_US
dc.subject.other Miscellaneous Medical en_US
dc.title Appetite stimulants use in cystic fibrosis en_US
dc.type Article en_US
dc.rights.robots IndexNoFollow en_US
dc.subject.hlbsecondlevel Pediatrics en_US
dc.subject.hlbtoplevel Health Sciences en_US
dc.description.peerreviewed Peer Reviewed en_US
dc.contributor.affiliationum Pediatric Pulmonology, University of Michigan Health System, Ann Arbor, Michigan ; Department of Pediatrics, University of Michigan Health System, 1500 E. Medical Center Dr., SPC 5212, Ann Arbor, MI 48109-5212. en_US
dc.contributor.affiliationother Clinical Nutrition Department, Montreal Children's Hospital, McGill University Health Centre, Montreal, Canada en_US
dc.identifier.pmid 18219690
dc.description.bitstreamurl http://deepblue.lib.umich.edu/bitstream/2027.42/57930/1/20766_ftp.pdf
dc.identifier.doi http://dx.doi.org/10.1002/ppul.20766 en_US
dc.identifier.source Pediatric Pulmonology en_US
dc.owningcollname Interdisciplinary and Peer-Reviewed
 Show simple item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Available Now


MLibrary logo